Company: EDSA
Filing Date: 2025-12-12
Form Type: 10-K
Source: 0001171843-25-007914
Chunk: 340

Company: Edesa Biotech, Inc.
Filing Date: 2025-12-12
Form: 10-K
Item: Item 1A
Chunk 340
---
			$
			141,877

			Peter Weiler

			5/29/25

			57,792
			(2) 
			 
			$
			142,746

			(1)

			Our options and RSU vesting policy is described in the Outstanding Equity Awards Narrative Disclosure section.

			(2)

			The option and RSUs vest over a period of three years, with monthly vesting on a pro-rata basis beginning on the date of grant.

			(3)
			The RSUs vest over a period of 18 months, with monthly vesting on a pro-rate basis beginning on the date of grant.

			(4)
			The RSUs vest over a period of 24 months, with monthly vesting on a pro-rate basis beginning on the date of grant.

			(5) 

			Represents the product of (i) $2.47 (which was the closing price of the common shares on September 30, 2025, the last trading day of fiscal 2025) and (ii) the number of common shares underlying the RSUs.

60

Outstanding Equity Awards Narrative Disclosure

Equity Incentive Compensation Plan

We adopted an Equity Incentive Compensation Plan in 2019 (as amended, the “2019 Plan”) which amended and restated prior plans. Under the 2019 Plan, we are authorized to grant options, restricted shares and restricted share units (“RSUs”) to any of our officers, directors, employees, and consultants and those of our subsidiaries and other designated affiliates. The number of shares available for issuance under the 2019 Plan is 2,367,737. The purpose of the 2019 Plan is to advance the interests of the Company by encouraging equity participation through the acquisition of common shares of the Company. The 2019 Plan is to be administered by the Compensation Committee of our Board, except to the extent (and subject to the limitations set forth in the 2019 Plan) the Board elects to administer the 2019 Plan, in which case the 2019 Plan shall be administered by only those members of the Board who are “independent” members of the Board. The administrator of the 2019 Plan has the power to, among other things:

			●

			allot common shares for issuance in connection with the exercise of options;

			●

			grant options, restricted shares or restricted share